Target intelligence / Profile preview

Plasmodium falciparum elongation factor 2 (PfeEF2)

Target
PfeEF2
Molecular classification
Enzyme, Translation elongation factor
01

Overview

Plasmodium falciparum elongation factor 2 (PfeEF2) is an essential enzyme that catalyzes the GTP-dependent translocation of the ribosome along messenger RNA, a critical step in protein synthesis. PfeEF2 plays a central role in the parasite's cytoplasmic translation machinery and is conserved among eukaryotes. It has been validated as a druggable target for antimalarial therapy; inhibitors such as DDD107498 disrupt parasite protein synthesis and kill multiple life cycle stages, supporting its use for both treatment and transmission blocking. Selectivity versus the host eEF2 is a design priority due to sequence homology, but successful selective inhibition demonstrates its value as a target for antimalarial drug development[3][4][6].

Other names
elongation factor 2eEF2EF2PF14_0486PF3D7_1451100Q8IKW5
02

Mechanism of action

Inhibition of protein synthesis via inhibition of GTP-dependent ribosomal translocation[3][4]

03

Biological functions

Protein synthesis (translation elongation)GTP-dependent ribosome translocationParasite–host interaction
04

Disease associations

Infection
05

Safety considerations

Potential selectivity challenge due to high homology with human eEF2[3][4]Risk of toxicity if selectivity not achieved[3]
06

Interacting drugs

DDD107498[3][4]

1 more in the full profile.

Beyond the preview

Go deeper on Plasmodium falciparum elongation factor 2 (PfeEF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum elongation factor 2 (PfeEF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call